Table 3.
Comparisons of single, autologous frozen-thawed blastocyst transfers between two luteal phase support regimes
| Daily IMP (n = 608) | Daily VP plus IMHPC (n = 159) | OR (95%CI) | p value | |
|---|---|---|---|---|
| Positive pregnancy test | 420 (69.1) | 110 (69.2) | 1.01 (0.68–1.46) | 0.980 |
| Biochemical pregnancy | 37 (6.1) | 7 (4.4) | 0.71 (0.31–1.62) | 0.416 |
| Implantation | 381 (62.7) | 102 (64.2) | 1.06 (0.74–1.53) | 0.730 |
| Clinical pregnancy | 362 (59.5) | 98 (61.6) | 1.09 (0.76–1.56) | 0.631 |
| Live birth | 315 (51.8) | 80 (50.3) | 0.94 (0.66–1.33) | 0.737 |
| Ectopic pregnancy | 2 (0.3) | 1 (0.6) | 1.91 (0.17–21.28) | 0.590 |
| Multiple pregnancy | 4 (0.7) | 2 (1.3) | 1.92 (0.34–10.59) | 0.445 |
Data are given as number (percentage). IMP, VP, and IMHPC denote intramuscular progesterone, vaginal progesterone, and intramuscular hydroxyprogesterone caproate. OR and CI denote odds ratio and confidential interval
IMP, VP and IMHPC denote intramuscular progesterone, vaginal progesterone and intramuscular hydroxyprogesterone caproate.
OR and CI denote odds ratio and confidential interval